Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Treatment of nodular facial angiofibromas in tuberous sclerosis, using ultrapulse carbon dioxide laser.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
  • المؤلفون: Biondo G;Biondo G; Greco S; Mavilia L; Mercuri SR
  • المصدر:
    Clinical and experimental dermatology [Clin Exp Dermatol] 2014 Aug; Vol. 39 (6), pp. 738-40. Date of Electronic Publication: 2014 May 30.
  • نوع النشر :
    Case Reports; Journal Article
  • اللغة:
    English
  • معلومة اضافية
    • المصدر:
      Publisher: Oxford University Press Country of Publication: England NLM ID: 7606847 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2230 (Electronic) Linking ISSN: 03076938 NLM ISO Abbreviation: Clin Exp Dermatol Subsets: MEDLINE
    • بيانات النشر:
      Publication: 2023- : Oxford : Oxford University Press
      Original Publication: Oxford : Blackwell Scientific Publications.
    • الموضوع:
      Angiofibroma/*surgery ; Facial Neoplasms/*surgery ; Laser Therapy/*methods ; Lasers, Gas/*therapeutic use ; Skin Neoplasms/*surgery ; Tuberous Sclerosis/*complications; Adult ; Carbon Dioxide ; Humans ; Male ; Treatment Outcome
    • نبذة مختصرة :
      Tuberous sclerosis (TS) is a genodermatosis characterized by facial angiofibromas (FAs). These tumours cause aesthetic disfigurement and obstruction of vision, and haemorrhage when traumatized, which can lead to emotional distress and relationship difficulties. We report the case of a 35-year-old patient with extensive TS-associated FAs that were treated with an ultrapulse carbon dioxide laser (UPCDL). UPCDL laser seems to be a easy, useful and convenient tool for the treatment of nodular FAs, which provides good aesthetic results, and a positive response from patients, who report high levels of satisfaction with the results. Minimal recurrence of the tumours occurred during long-term follow-up, and these were successfully treated with UPCDL. It is not yet possible to correct the genetic alterations underlying TS, but UPCDL treatment is a convenient tool to improve the facial appearance of patients with severe FAs.
      (© 2014 British Association of Dermatologists.)
    • الرقم المعرف:
      142M471B3J (Carbon Dioxide)
    • الموضوع:
      Date Created: 20140604 Date Completed: 20150305 Latest Revision: 20140721
    • الموضوع:
      20240829
    • الرقم المعرف:
      10.1111/ced.12327
    • الرقم المعرف:
      24890518